Ireland invests Euros20m in breast screening roll-out
This article was originally published in Clinica
Ireland's BreastCheck programme has been awarded Euros20m ($24m) to build the clinics and buy the mobile units needed to extend the screening and treatment service nationally. The capital investment funding aims to provide screening coverage for all women in the 50-64 years age group within the next three years, adding more than 130,000 women to the programme.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.